BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Federal Trade Commission
US Department of Justice

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,599,530

« Back to Dashboard

Which drugs does patent 6,599,530 protect, and when does it expire?

Patent 6,599,530 protects COMTAN and is included in one NDA. There has been one Paragraph IV challenge on Comtan.

This patent has forty-five patent family members in thirty-seven countries.

Summary for Patent: 6,599,530

Title: Oral compacted composition comprising catechol derivatives
Abstract:The present invention relates to an oral compacted composition comprising entacapone, nitecapone, or a pharmaceutically acceptable salt thereof and croscarmellose sodium. The composition is premised on the discovery that croscarmellose sodium increases the release rate of entacapone or nitecapone from an oral compacted composition. Preferably the amount of croscarmellose sodium in the composition is at least 6% by weight, preferably from about 8% to about 16% by weight, especially from about 10% to about 14% by weight.
Inventor(s): Vahervuo; Kari (Espoo, FI)
Assignee: Orion Corporation (Espoo, FI)
Application Number:09/152,263
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation; Process; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Orion Pharma
TABLET;ORAL020796-001Oct 19, 1999ABRXYesYes► Subscribe► SubscribeY TREATMENT OF PARKINSON'S DISEASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,599,530

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina021806► Subscribe
Austria256454► Subscribe
Australia5748299► Subscribe
Australia746889► Subscribe
Bulgaria105436► Subscribe
Bulgaria65041► Subscribe
Brazil9913681► Subscribe
Canada2342634► Subscribe
China1151778► Subscribe
China1319005► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Queensland Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus